Robert Ticktin
Director de Operaciones en PMV PHARMACEUTICALS, INC. .
Cargos activos de Robert Ticktin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director de Operaciones | - | - |
| Consejero General | - | - |
Historial de carrera de Robert Ticktin
Antiguos cargos conocidos de Robert Ticktin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TESARO INC | Corporate Officer/Principal | - | - |
EPIRUS Biopharmaceuticals, Inc. /Old/
 EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | Consejero General | 01/04/2014 | - |
| EPIRUS BIOPHARMACEUTICALS, INC. | Consejero General | - | - |
| Secretario Corporativo | - | - | |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Consejero General | - | - |
Formación de Robert Ticktin.
| The Ohio State University | Undergraduate Degree |
| Fordham University School of Law | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| General Counsel | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| Empresas privadas | 3 |
|---|---|
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Ticktin
- Experiencia